ライフサイエンスコーパス: pulmonary vein isolation

1 fibrillation after contact force (CF)-guided pulmonary vein isolation.

2 as terminated in 20 patients (38%) after the pulmonary vein isolation.

3 required spot-ablations to complete electric pulmonary vein isolation.

4 logic study, symptomatic AFL is common after pulmonary vein isolation.

5 is a novel, nonthermal ablation modality for pulmonary vein isolation.

6 nd may require more extensive treatment than pulmonary vein isolation.

7 Patients with paroxysmal AF underwent pulmonary vein isolation.

8 ed during sinus rhythm in 22 patients before pulmonary vein isolation.

9 before video-assisted thoracoscopic surgical pulmonary vein isolation.

10 paroxysmal AF who were scheduled to undergo pulmonary vein isolation.

11 0 patients; 28%) underwent cryoballoon-based pulmonary vein isolation.

12 ed during sinus rhythm after circumferential pulmonary vein isolation.

13 xation time on CMR and freedom from AF after pulmonary vein isolation.

14 ong association with late recurrent AF after pulmonary vein isolation.

15 All patients underwent successful pulmonary vein isolation.

16 (focal impulse and rotor modulation) before pulmonary vein isolation.

17 AD) therapy in patients with previous failed pulmonary vein isolation.

18 mber of patients with nonparoxysmal AF after pulmonary vein isolation.

19 In the group that underwent pulmonary-vein isolation, 88% of patients receiving anti

20 atients undergoing CF-guided circumferential pulmonary vein isolation, 914 radiofrequency application

21 After successful pulmonary vein isolation, a bonus freeze was applied.

22 on, a limited Cox-Maze procedure (n = 7), or pulmonary vein isolation alone (n = 23).

23 Pulmonary vein isolation alone cannot explain the discre

24 group, limited Cox-Maze procedure group, and pulmonary vein isolation alone group, respectively.

25 Pulmonary vein isolation alone was much less effective,

26 procedure, a limited Cox-Maze procedure, or pulmonary vein isolation alone.

27 ad undergone cardiac surgery exclusively for pulmonary vein isolation and 17 had no structural heart

28 During video-assisted thoracoscopic surgical pulmonary vein isolation and CARTO mapping, BrS patients

29 ry, 14 months; Q1-Q3, 7-36 months) underwent pulmonary vein isolation and completed the entire follow

30 ents with nonparoxysmal AF undergoing antral pulmonary vein isolation and nonpulmonary vein trigger a

31 CA consisted of linear antral pulmonary vein isolation and optional additional lines.

32 CA included pulmonary vein isolation and posterior wall isolation.

33 nt AF and 22 with long-lasting AF, underwent pulmonary vein isolation and substrate modification of c

34 We performed pulmonary vein isolation and voltage mapping in 236 pati

35 variable, an ablation strategy that involves pulmonary vein isolation and/or a particular set of abla

36 fibrillation between patients who underwent pulmonary-vein isolation and those who underwent the bia

37 and 9 +/- 10 months for the Cox-Maze IV, the pulmonary vein isolation, and the limited Cox-Maze proce

38 In all, 41 patients underwent pulmonary-vein isolation, and 40 underwent atrioventricu

39 ted atrial electrograms (CFAEs) after antral pulmonary vein isolation (APVI) further improves the cli

40 le-lung transplantation surgery both involve pulmonary vein isolation because of suture lines.

41 Current guidelines recommend pulmonary-vein isolation by means of catheter ablation a

42 An anatomic approach to complete pulmonary vein isolation could overcome these limitation

43 Empiric circumferential pulmonary vein isolation (CPVI) has become the therapy o

44 ) and the surgical maze procedure (including pulmonary vein isolation) done during other cardiac surg

45 ablation using a stepwise ablation approach (pulmonary vein isolation, electrogram-guided, and linear

46 en; 61 long-lasting persistent AF) underwent pulmonary vein isolation followed by electrogram-guided

47 urrence substantially limits the efficacy of pulmonary vein isolation for AF and is associated with p

48 THODS AND Ten consecutive patients underwent pulmonary vein isolation for persistent atrial fibrillat

49 Contact force parameters evaluated during pulmonary vein isolation for treating atrial fibrillatio

50 in the Cox-Maze procedure group and 1 in the pulmonary vein isolation group.

51 Although pulmonary vein isolation has become a mainstream therapy

52 ducibility of atrial fibrillation (AF) after pulmonary vein isolation has been used to guide addition

53 Pulmonary vein isolation has increasingly been used to c

54 In humans, variability of CF during pulmonary vein isolation has not been characterized.

55 uspid isthmus ablation is appropriate during pulmonary vein isolation if AFL has been observed clinic

56 hereas CFAE ablation in addition to standard pulmonary vein isolation improves outcomes in patients w

57 acute), and later than 3 months (late) after pulmonary vein isolation in 25 patients with paroxysmal

58 se, Geneva, Switzerland) was used to perform pulmonary vein isolation in 46 patients with paroxysmal

59 lation strategies in the LAAI group included pulmonary vein isolation in 50 (100%), left atrial isthm

60 -13 minutes for STA (P<0.001) with confirmed pulmonary vein isolation in all patients.

61 e targeted for ablation, in conjunction with pulmonary vein isolation in most patients (n=19; 79%).

62 ce atrial fibrillation (AF) recurrence after pulmonary vein isolation in patients with paroxysmal AF.

63 ) and cryoballoon catheter (CB) ablation for pulmonary vein isolation in patients with paroxysmal atr

64 The use of second-generation cryoballoon for pulmonary vein isolation in patients with paroxysmal atr

65 g CFAEs have been compared with the standard pulmonary vein isolation in persistent as well as paroxy

66 for prevention of early AF recurrences after pulmonary vein isolation in the absence of antiarrhythmi

67 modification in addition to circumferential pulmonary vein isolation irrespective of AF type.

68 Pulmonary vein isolation is a new, effective curative pr

69 Pulmonary vein isolation is an effective treatment for A

70 Pulmonary vein isolation is an established treatment opt

71 Pulmonary vein isolation is better than antiarrhythmic m

72 Pulmonary vein reconnection after pulmonary vein isolation is common and is usually associ

73 its high success and low complication rate, pulmonary vein isolation is expected to be increasingly

74 rial fibrillation (AF) failing to respond to pulmonary vein isolation is important.

75 The clinical efficacy of pulmonary vein isolation is much lower when AF is persis

76 Pulmonary vein isolation is the cornerstone of ablation

77 Pulmonary vein isolation is the most prevalent approach

78 Pulmonary-vein isolation is increasingly being used to t

79 went epicardial thoracoscopic radiofrequency pulmonary vein isolation, linear ablation, Marshal ligam

80 Although pulmonary vein isolation of any means/energy source is t

81 l fibrillation before electric cardioversion/pulmonary vein isolation or after cardioembolic cerebrov

82 ion group underwent further randomization to pulmonary-vein isolation or a biatrial maze procedure.

83 ss II or III heart failure to undergo either pulmonary-vein isolation or atrioventricular-node ablati

84 Ablation was performed by circumferential pulmonary vein isolation plus linear ablation of extrapu

85 reablation after a previously failed initial pulmonary vein isolation procedure were eligible for thi

86 ODS AND We analyzed 42 CF-guided ipsilateral pulmonary vein isolation procedures.

87 In the group that underwent pulmonary-vein isolation, pulmonary-vein stenosis develo

88 to compare arrhythmia-free survival between pulmonary vein isolation (PVI) and a stepwise approach (

89 cryoballoon is effective in achieving acute pulmonary vein isolation (PVI) and favorable clinical ou

90 es recommend a 3-month blanking period after pulmonary vein isolation (PVI) as early recurrence of at

91 Atrial fibrillation (AF) may recur after pulmonary vein isolation (PVI) as the result of either r

92 nd-generation cryoballoon delivers effective pulmonary vein isolation (PVI) associated with superior

93 can be challenging, often involving not only pulmonary vein isolation (PVI) but also additional linea

94 gate whether the combination of conventional pulmonary vein isolation (PVI) by circumferential antral

95 Pulmonary vein isolation (PVI) for atrial fibrillation i

96 Pulmonary vein isolation (PVI) for persistent atrial fib

97 ess and complications in patients undergoing pulmonary vein isolation (PVI) for treatment of atrial f

98 For the past decade, electric pulmonary vein isolation (PVI) has become a procedure im

99 imed to determine the safety and efficacy of pulmonary vein isolation (PVI) in atrial fibrillation (A

100 s the impact of CFAE ablation in addition to pulmonary vein isolation (PVI) in patients undergoing ab

101 Pulmonary vein isolation (PVI) is a recommended treatmen

102 The single-procedure efficacy of pulmonary vein isolation (PVI) is less than optimal in p

103 Pulmonary vein isolation (PVI) is still associated with

104 It is not known whether complete pulmonary vein isolation (PVI) is superior to incomplete

105 tions include not only the durability of the pulmonary vein isolation (PVI) lines, but also the patho

106 We hypothesized that pulmonary vein isolation (PVI) plus ablation of selectiv

107 Despite the fact that pulmonary vein isolation (PVI) should be performed proph

108 resistant hypertension who were referred for pulmonary vein isolation (PVI).

109 confidence level >7 were ablated followed by pulmonary vein isolation (PVI).

110 ith obstructive sleep apnea (OSA) undergoing pulmonary vein isolation (PVI).

111 AF/AT recurrence is common after pulmonary vein isolation (PVI).

112 nitial ablation strategy was circumferential pulmonary vein isolation (PVI).

113 transesophageal echocardiogram (TEE) before pulmonary vein isolation (PVI); and 2) the relationship

114 In CF-guided pulmonary vein isolation, PVR is explained by lack of bo

115 in patients undergoing robotically assisted pulmonary vein isolation (RA-PVI) as compared with manua

116 CF during pulmonary vein isolation remains highly variable despite

117 Antral pulmonary vein isolation resulted in termination of AF i

118 ablation at these sites, in conjunction with pulmonary vein isolation, resulted in AF termination or

119 ion to investigate the hypothesis that acute pulmonary vein isolation results from a combination of i

120 e of second-generation 28-mm cryoballoon for pulmonary vein isolation results in an 80% 1-year succes

121 The contact force during pulmonary vein isolation should be a target of 10-20 g o

122 icular contractions at the large majority of pulmonary vein isolation sites.

123 h a conventional ablation approach was used (pulmonary vein isolation/stepwise approach).

124 In addition to pulmonary vein isolation, substrate modification and tri

125 ciation between LAPEF and recurrent AF after pulmonary vein isolation that persisted after multivaria

126 onitoring in the ADVICE (Adenosine Following Pulmonary Vein Isolation to Target Dormant Conduction El

127 on techniques may facilitate safe and simple pulmonary vein isolation to treat paroxysmal atrial fibr

128 ed tomography (CT) before and 3 months after pulmonary vein isolation using duty-cycled phased radio

129 balloon (LB) with wide-area circumferential pulmonary vein isolation using irrigated radiofrequency

130 imilar efficacy as wide-area circumferential pulmonary vein isolation using irrigated RF in patients

131 tiarrhythmic drug(s), who were scheduled for pulmonary vein isolation using second-generation cryobal

132 Pulmonary vein isolation using standard radiofrequency a

133 ulceration and fistula are complications of pulmonary vein isolation using thermal energy sources.

134 risk of pulmonary vein narrowing (PVN) after pulmonary vein isolation, using a novel multi-electrode

135 educing AF recurrence, SOE was high favoring pulmonary vein isolation versus antiarrhythmic medicatio

136 Multielectrode pulmonary vein isolation versus single tip wide area cat

137 Pulmonary vein isolation was complete in 338 of the 358

138 Pulmonary vein isolation was confirmed by intraoperative

139 Pulmonary vein isolation was performed in 133 consecutiv

140 udy included 140 patients (43 women) in whom pulmonary vein isolation was performed using a second-ge

141 Pulmonary vein isolation was performed with a cryoballoo

142 Pulmonary-vein isolation was superior to atrioventricula

143 th paroxysmal atrial fibrillation undergoing pulmonary vein isolation were followed for 12 months wit

144 etic resonance pulmonary vein mapping before pulmonary vein isolation were included.

145 s circular lesions, deep enough for electric pulmonary vein isolation, were created with a single cir

146 in the left atrium and coronary sinus after pulmonary vein isolation, were enrolled.

147 brillation (AF) recurrences than wide antral pulmonary vein isolation (wide antral isolation [WAI]) b

148 Ablation included pulmonary vein isolation with confirmed entrance block a

149 y end point favored the group that underwent pulmonary-vein isolation, with an improved questionnaire

150 had similar rates of single-procedure acute pulmonary vein isolation without serious adverse events